Zagrebacka Banka d.d. (ZABA)
Zagreb Stock Exchange · Croatia · prices in EUR · close of 14 Oct 2026
Key indicators
| Last close | EUR 23.90 |
|---|---|
| 52-week range | 19.80 – 24.80 |
| Return, 1 month / 3 months | +0.0% / +5.8% |
| Return, 1 year / 3 years | −0.8% / +92.7% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 21.3% |
| Worst drawdown (1 year) | -18.6% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Zagrebacka Banka is a Croatian commercial bank based in Zagreb. It serves individuals, small businesses, large companies and public institutions, offering current and savings accounts, loans, payment cards, mortgages and insurance products, alongside corporate and investment banking services such as financing and advisory work. The bank operates a branch network across Croatia and is part of the UniCredit banking group, which shapes its product range and international links.
The shares are listed on the Zagreb Stock Exchange in Croatia under the code ZABA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Zagrebacka Banka d.d. (ZABA) trades on the Zagreb Stock Exchange in Croatia. It last closed at EUR 23.90 on 14 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 22 of 45 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.8% and over the last three months it rose 5.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Zagreb Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.9% | ||
| From 52-week high | -3.2% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.8% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | -0.8% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 21.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.6% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 100.0% | ||
| Income | 75 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 5 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +0.0% |
| 3 months | +5.8% |
| 6 months | +0.0% |
| 1 year | −0.8% |
| 3 years | +92.7% |
| 5 years | +165.4% |
Signals
| 50-day / 200-day average | 23.04 / 23.00 |
|---|---|
| Golden / death cross (60 days) | Golden, 1 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Apr 2026 | EUR 1.2700 |
| 14 Apr 2025 | EUR 1.4000 |
| 16 Apr 2024 | EUR 1.4000 |
| 12 Apr 2023 | EUR 1.6900 |
| 13 Apr 2022 | EUR 0.8304 |
| 16 Apr 2019 | EUR 0.7785 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Zagreb Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.